Latest filing published 24 Jul 2026 for Angiodynamics INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Laura Piccinini in Angiodynamics Inc, where the filings describe the role as senior executive. We count 20 filings; the first trade dates from 21 July 2021 and the latest from 22 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 24 July 2026, reports an option exercise in Angiodynamics Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations